SINOPEP ALLSINO
GenericsSINOPEP ALLSINO is a generic drug manufacturer focused on Oncology.
SINOPEP ALLSINO's Key Drugs
SINOPEP ALLSINO's key approved drugs from the last 15 years (excludes generics, biosimilars and IV formulations).
SINOPEP ALLSINO's Recent FDA Approvals
New NDA/BLA approvals for SINOPEP ALLSINO over the last two years — novel drugs only, excluding generics and label supplements.
SINOPEP ALLSINO's Therapeutic Areas
SINOPEP ALLSINO's approved drugs and pipeline span 1 therapeutic area, led by Oncology. Weighted by commercial stage — approved drugs count most, then late-stage trials.
SINOPEP ALLSINO's Top Competitors
SINOPEP ALLSINO's closest competitors by therapeutic-area and drug-target overlap include Pfizer, Novartis, and Merck. Ranked by overlap in therapeutic areas and drug targets across approved drugs and pipeline.
SINOPEP ALLSINO Pipeline Snapshot
Active clinical trials for SINOPEP ALLSINO across all therapeutic areas, from ClinicalTrials.gov.
Pro Intelligence Preview
Deep insights for investors and analysts
Revenue Insights
- • Top drug revenue breakdown
- • Drug-level revenue analysis
Trial Catalysts
- • Oncology pipeline focus
- • Phase 3 readout tracking
Patent Risk
- • Patent expiration timeline
- • Revenue at risk analysis
Compare Companies
- • Side-by-side pipeline analysis
- • Revenue & market share comparison
Revenue forecasts • Trial milestones • Patent risk modeling
Active (0)
Discontinued (0)
Company Info
- First Approval
- 2026-10-28
- Latest
- 2026-10-28
- Applications
- 1